In comparison, DLAT was lowly expressed in 5 types of cancers: adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), head and Neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIRC), and acute myeloid leukemia (LAML) (Fig. 1A). Here, DLAT is linked to adrenal cortex carcinoma.